Embryonic rat dorsal root ganglia organotypic culture: a morphometric model to test neurotoxicology by Nicolini, Gabriella et al.
IJAE 
Vo l .  117,  n .  2  (Supp lem ent) :  137,  2012
© 2012 Firenze University Press 
ht tp://www.fupress .com/ijae
ItalIan Journal of anatomy and Embryology
embryonic rat dorsal root ganglia organotypic culture: 
a morphometric model to test neurotoxicology 
Gabriella Nicolini1, Mariarosaria Miloso1, Daniele Maggioni1, Lucilla Nobbio2 and Giovanni Tredici1
1 Dipartimento di Neuroscienze e Tecnologie Biomediche, Università degli Studi di Milano-Bicocca, Milano, Italy
2 Dipartimento di Neuroscienze, Oftalmologia e Genetica (DiNOG) e Centro di Eccellenza per la Ricerca 
Biomedica (CEBR), Università di Genova, Genova, Italy
Neurotoxicity is a common dose-limiting side-effect of several drugs (Cavaletti 
et al., 2008). So far a validated test method to screen drugs neurotoxicity does not 
exist, therefore in this interdepartment study we have analyzed the effectiveness of 
a morphometric neurotoxicty assessment model. Drug neurotoxicity evaluation is 
based on embryonic rat dorsal root ganglia (DRG) organotypic culture. DRG primary 
sensory neurons are the principal target of drugs neurotoxic action. In fact, prima-
ry sensory neurons lie outside the blood-nerve barrier and are supplied by capillar-
ies with fenestrated walls. Moreover, the axons of these cells are among the longest 
of the entire nervous system and, therefore, are more susceptible to any agent that 
interferes with the energy metabolism or the structural basis of axonal transport. In 
particular, in this interdepartment study, the interference of the under study neuro-
toxic compound with NGF-induced neurite elongation is analysed. The effectiveness 
and reproducibility of this model, even if commonly used to test drugs, has not yet 
been demonstrated. In order to assess the validity of this in vitro model, antineo-
plastic drugs known to be in clinical use and in animal models neurotoxic (paclitaxel 
and oxaliplatin) or not dangerous (cyclophosphamide and 5-Fluorouracil) have been 
tested. DRGs explanted from E15 rat embryos have been treated for 24h with drugs 
concentrations comparable to those achievable in vivo. The length of the longest neu-
rite of each DRG has been measured by ImageJ program. Experiments have been per-
formed by three different blinded researchers in two different laboratories. Mean and 
standard deviation of each experiment were obtained, subsequently the mean value 
and standard deviation of the three independent experiments for each researcher 
were calculated. Data obtained by the three researchers in two different laboratories 
resulted statistically comparable and no significant differences were detected (One 
Way Anova analysis of variance and Tukey post test; p<0.05). This interdepartment 
in vitro study, therefore, indicates that a purely morphometric model represents a 
reliable tool to study drug neurotoxicity, permitting to make prediction of neurotoxic 
effects on humans because the concentrations tested are the same to which DRG are 
exposed during clinical use.
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